APOBEC3B and cancer: Cellular APOBEC3 enzymes, predominantly APOBEC3B (A3B) and APOBEC3A (A3A)18–21, generate SBS2 and SBS13 mutational signatures and represent the second most common mutational process in human cancer (following aging-associated processes; viz., SBS1 and SBS5)3.